Navigation Links
Justifying the use of letrozole for inducing ovulation

Letrozole used for the treatment of advanced/metastatic breast cancer in postmenopausal women is also being used by // infertility specialists as a second line of treatment for infertility for inducing ovulation. Studies indicate that letrozole was used not on an experimental basis, but as an accepted safe drug for inducing ovulation.

However some feel that without clinical trials to ascertain any possible side effect, prescribing the drug Letrozole for infertility is unethical and illegal. Another argument is that, since the drug is used for a short duration of 5 days its effect is short acting and the side effects would be minimum or practically nil. It is also said that since the drug is administered before ovulation and fertilization, there is no question of teratogenicity (malformation of the fetus) when compared to injectible gonado tropins used for treating infertility which are associated with a higher incidence of multiple pregnancies.

It is argued that the practice of medicine is regulated by Medical Council of India, and not by the Drugs Controller hence they feel that drug controller can introduce a new drug for marketing, or ban a particular drug from being sold but should not be given the right to designate a particular drug for a particular disease, to be prescribed by a particular section of doctors.

Letrozole could be prescribed only for treating breast cancer and not for inducing ovulation as per the permission given by the Drugs Controller General of India (DCGI). However it is said that doctors cannot be asked not to prescribe it , instead ask the drug store owners not to honor any prescriptions violating existing norms stipulated by the Drugs Controller's office.

A doctor specializing in oncology and women's diseases from a city based hospital 'A cure for incurable ‘, says that the use of letrozole in a healthy women if used for ovulation may lead to developing cancer of ovary, breast or any other part of the body and the chance is one in every one thousand. Hence he concludes saying that homeopathic medicines are better alternatives for inducing ovulation as they do not have any side effect.
'"/>




Related medicine news :

1. Therapy inducing self-repair of nerves to help Alzheimer’
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: